The “Dual-Pathway” Strategy after Acute Coronary Syndrome:...

Cardiovascular Therapeutics 2014 / 10 Vol. 32; Iss. 5

The “Dual-Pathway” Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial

Cohen, Marc, Iyer, Deepa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Cardiovascular Therapeutics
DOI:
10.1111/1755-5922.12083
Date:
October, 2014
File:
PDF, 630 KB
english, 2014
Conversion to is in progress
Conversion to is failed